Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line

Proteomics

Volumn 9, Issue 6, 2009, Pages 1556-1566

  Keenan, Joanne ^a   Murphy, Lisa ^a   Henry, Michael ^a   Meleady, Paula ^a   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Differential protein expression; Lung cancer; Multidrug resistance

Indexed keywords

ALDEHYDE DEHYDROGENASE; ANNEXIN; BETA TUBULIN; CHAPERONIN; DOXORUBICIN; G ACTIN; GALECTIN 1; GLUCOSE REGULATED PROTEIN 78; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; INITIATION FACTOR 5A; LIPOCORTIN 1; NUCLEOSIDE DIPHOSPHATE KINASE; PEROXIREDOXIN; PROHIBITIN; PROTEIN; PROTEIN DISULFIDE ISOMERASE; REACTIVE OXYGEN METABOLITE; STOMATIN; THIOREDOXIN; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LUNG CANCER; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEOMICS; REACTIVE OXYGEN SPECIES; REPRODUCIBILITY OF RESULTS; STAUROSPORINE;

EID: 63049102412     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800633     Document Type: Article

References (48)

1. Seve, P., Dumontet, C., Chemoresistance in non-small cell lung cancer. Curr. Med. Chem.-Anti Cancer Agents 2005, 5, 73-88.
2. Danesi, R., De Braud, F., Fogli, S., De Pas, T. M. et al., Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer. Pharmacol. Rev. 2003, 55, 57-103.
3. Jemal, A., Siegel, R., Ward, E., Murry, T. et al., Cancer Statistics 2006. CA Cancer J. Clin. 2006, 56, 106-130.
4. Omenn, G. S., Human lung cancer chemoprevention strategies: Parker B Francis Lecture. Chest 2004, 125, 123S-127S.
5. Gao, W. M., Kuick, R., Orchekowshi, R. P., Misek, D. E. et al., Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer 2005, 5, 110.
6. Clynes, M., Daly, C., NicAmhlaoibh, R., Cronin, D. et al., Recent developments in drug resistance and apoptosis research. Crit. Rev. Oncol. Hematol. 1998, 28, 181-205.
7. Skovsgaard, T., Nielsen, D., Maare, C., Wassermann, K., Cellular resistance to cancer chemotherapy. Int. Rev. Cytol. 1994, 156, 77-157.
8. Noguchi, M., Kabayama, K., Uemura, S., Kang, B. et al., Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells. Glycobiology 2006, 16, 641-650.
9. Lage, H., Proteomics in cancer cell research: an analysis of therapy resistance. Pathol. Res. Pract. 2004, 200, 105-117.
10. Righetti, P. G., Castagna, A., Antonioli, P., Cecconi, D. et al., Proteomic approaches for studying chemoresistance in cancer. Expert Rev. Proteomics 2005, 2, 215-228.
11. Heenan, M., O'Driscoll, L., Cleary, I., Connolly, L., Clynes, M., Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance. Int. J. Cancer 1997, 71, 907-915.
12. Law, E., Gilvarry, U., Lynch, V., Gregory, G. et al., Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines. Cancer Genet. Cytogenet. 1992, 59, 111-118.
13. Cleary, I., Doherty, G., Moran, E., Clynes, M., The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochem. Pharmacol. 1997, 53, 1493-1502.
14. Clynes, M., Redmond, A., Moran, E., Gilvarry, U., Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A. Cytotechnology 1992, 10, 75-89.
15. Beissbarth, T., Speed, T. P., GOstat: find statistically over-represented gene ontologies within a group of genes. Bioinformatics 2004, 20, 1464-1465.
16. Laemmli, E., Favre, M., Mutation of the head of bacteriophage T4. J. Mol. Biol. 1973, 80, 575-579.
17. Towbin, H., Staehelin, T., Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc. Natl. Acad. Sci. USA 1979, 76, 4350-4354.
18. Martin, A., Clynes, M., Comparison of 5 microplate colorimetric assays for in vitro cytotoxicity testing and cell proliferation assays. Cytotechnology 1993, 11, 49-58.
19. Albini, A., Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol. Oncol. Res. 1998, 4, 230-241.
20. Wang, H., Guan, J., Perrault, A. R., Wang, Y. et al., Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase 1. Cancer Res. 2001, 61, 8554-8563.
21. Sinha, P., Poland, J., Kohl, S., Schnolzer, M. et al., Study of the development of chemoresistance in melanoma cell lines using proteome analysis. Electrophoresis 2003, 24, 2386-2404.
22. Calderwood, S. K., Khalegue, M. A., Sawyer, D. B., Ciocca, D. R., Heat shock proteins in cancer: chaperones of tumorigenesis. TBS 2006, 31, 164-172.
23. Nadin, S. B., Vargas-Roig, L. M., Cuello-Carrión, F. D., Ciocca, D. R., Deoxyribonucleic acid damage induced by doxorubicin in peripheral blood mononuclear cells: possible roles for the stress response and the deoxyribonucleic acid repair process. Cell Stress Chaperones 2003, 8, 361-372.
24. Arrigo, A. P., Paul, C., Duchase, C., Small stress proteins: novel negative modulators of apoptosis induced independently of reactive oxygen species. Prog. Mol. Subcell. Biol. 2002, 28, 185-204.
25. Chauhan, D., Li, G., Auclair, D., Hideshima, T., Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiplemyeloma cells using oligonucleotide arrays. Blood 2003, 101, 3606-3614.
26. Zhou, G., Li, H., Gong, Y., Zhao, Y. et al., Proteomic analysis of global alteration of protein expression in squamous cell carcinoma of the esophagus. Proteomics 2005, 5, 3814-3821.
27. Garrido, C., Bruey, J. M., Fromentin, A., Hammann, A. et al., HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J. 1999, 13, 2061-2070.
28. Ciocca, D. R., Calderwood, S. K., Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005, 10, 86-103.
29. Mambula, S. S., Calderwood, S. K., Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J. Immunol. 2006, 177, 7849-7857.
30. Takayama, S., Krajewski, S., Krajewski, M., Kitada, S. et al., Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res. 1998, 58, 3116-3131.
31. L, but not by Bcl-2 or caspase inhibitors, allows the extensive differentiation of human neuroblastoma cells. J. Neurochem. 2002, 80, 126-139.
32. Verrills, N. M., Liem, N. L., Liaw, T. Y., Hood, B. D. et al., Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia-an in vivo study. Proteomics 2006, 6, 1681-1694.
33. Thiede, B., Siejak, F., Dimmler, C., Rudel, T., Prediction of translocation and cleavage of heterogeneous ribonuclear proteins and Rho guanine nucleotide dissociation inhibitor 2 during apoptosis by subcellular proteome analysis. Proteomics 2002, 2, 996-1006.
34. Taylor, C. A., Senchyna, M., Flanagan, J., Joyce, E. M. et al., Role of EIF-5A in TNF-alpha-mediated apoptosis of lamina cribrosa cells. Invest. Ophthalmol. Vis. Sci. 2004, 45, 3568-3577.
35. Fusaro, G., Wang, S., Chellappan, S., Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis. Oncogene 2002, 21, 4539-4548.
36. Zhu, B., Fukada, K., Zhu, H., Kyprianou, N., Prohibitin and Cofilin are intracellular effectors of transforming growth factor Beta signalling in human prostate cancer cells. Cancer Res. 2006, 66, 8640-8647.
37. Pyrko, P., Schonthal, A. H., Hofman, F. M., Chen, T. C., Lee, A. S., The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res. 2007, 67, 9809-9816.
38. Fu, Y., Li, J., Lee, A. S., GRP78/BiP inhibits endoplasmic reticulum BIK and protects breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res. 2007, 67, 3734-3740.
39. Liu, S. H., Lin, C. Y., Peng, S. Y., Jeng, Y. M. et al., Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am. J. Pathol. 2002, 160, 1831-1837.
40. Creagh, E. M., Sheehan, D., Cotter, T. G., Heat shock proteins-modulators of apoptosis in tumour cells. Leukemia 2000, 14, 1161-1173.
41. Park, J. H., Kim, Y. S., Lee, H. L., Shim, J. Y. et al., Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology 2006, 11, 269-275.
42. Chang, J. W., Jeon, H. B., Lee, J. H., Yoo, J. S. et al., Augmented expression of peroxiredoxin I in lung cancer. Biochem. Biophys. Res. Comm. 2001, 289, 507-512.
43. Hartsough, M. L., Steeg, P. S., Nm23/nucleoside diphosphate kinase in human cancers. J. Bioenerg. Biomembr. 2000, 32, 301-308.
44. Cumming, R. C., Andon, N. L., Haynes, P. A., Park, M. et al., Protein disulfide bond formation in the cytoplasm during oxidative stress. J. Biol. Chem. 2004, 279, 21749-21758.
45. Pardo, M., Garcia, A., Thomas, B., Pineiro, A. et al., The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int. J. Cancer 2006, 119, 1014-1022.
46. Zhou, W., Freed, C. R., DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53Talpha-synuclein toxicity. J. Biol. Chem. 2005, 280, 43150-43158.
47. Lindahl, R., Aldehyde dehydrogenases- the 1992 perspective. Crit. Rev. Biochem. Mol. Biol. 1992, 27, 283-335.
48. Tsukamoto, N., Chen, J., Yoshida, A., Enhanced expression of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukaemia cells. Blood Cells Mol. Dis. 1998, 24, 231-238.